VEGFD and lymphangioleiomyomatosis: Rossi et al. [92] analyzed the serum miRNA expression profiles of 27 LAM patients and 33 healthy subjects and found that miR-1972 and miR-186-5p are potential serum biomarkers for LAM, particularly when combined with miR-320 family members, especially in cases where other clinical standards, such as VEGF-D concentration, are insufficient.